Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China.
World J Pediatr. 2019 Aug;15(4):405-411. doi: 10.1007/s12519-019-00243-5. Epub 2019 Mar 25.
The limited available studies have unveiled different natural histories and prognosis associated with pediatric type 2 diabetes (T2D) and adult T2D. To date, data on the clinical features, metabolic profiles and beta-cell function characteristics are still limited in the Chinese pediatric T2D population.
A total of 56 children with T2D, 31 with prediabetes and 159 with obesity were recruited. Clinical characteristics, metabolic profiles, beta-cell function and insulin resistance were analyzed.
The mean onset age of T2D was 12.35 ± 1.99 (7.9-17.8) years, and 7% of children were younger than 10 years; 55% of them were male, 57% had a family history of diabetes and 64% had classic symptoms, and 25% had a low or high birth weight. 89% of T2D patients were obese or overweight. A total of 58% of the patients with prediabetes were male. The fast serum C-peptide level was highest in the obesity group (P < 0.001), and there was no significant difference between the T2D and prediabetes groups. The mean homeostatic model of assessment of beta-cell function was the highest in the obesity group and was lowest in the T2D group (P < 0.001). The T2D group had the most serious lipid metabolism disorder, with the highest levels of total triglycerides, total cholesterol, and low density lipoprotein and the lowest high density lipoprotein level among the three groups.
A younger onset age and greater male susceptibility were found in Chinese pediatric T2D patients, and there was a stepwise deterioration trend in beta-cell function among patients with obesity, prediabetes and T2D. Based on our results, together with the SEARCH study results, an early screening and intervention program for T2D is recommended in high-risk or obese Chinese pediatric populations starting at 7 years.
有限的研究揭示了儿科 2 型糖尿病(T2D)和成人 T2D 相关的不同自然史和预后。迄今为止,中国儿科 T2D 人群的临床特征、代谢特征和胰岛β细胞功能特征数据仍然有限。
共纳入 56 例 T2D 患儿、31 例糖尿病前期患儿和 159 例肥胖患儿。分析临床特征、代谢特征、胰岛β细胞功能和胰岛素抵抗。
T2D 的平均发病年龄为 12.35±1.99(7.9-17.8)岁,7%的患儿年龄小于 10 岁;55%为男性,57%有糖尿病家族史,64%有典型症状,25%有低出生体重或高出生体重。89%的 T2D 患儿肥胖或超重。糖尿病前期患者中,58%为男性。肥胖组血清 C 肽快速水平最高(P<0.001),T2D 组和糖尿病前期组之间无显著差异。肥胖组稳态模型评估的胰岛β细胞功能平均值最高,T2D 组最低(P<0.001)。T2D 组脂代谢紊乱最严重,三组中总甘油三酯、总胆固醇、低密度脂蛋白水平最高,高密度脂蛋白水平最低。
中国儿科 T2D 患者发病年龄更小,男性易感性更高,肥胖、糖尿病前期和 T2D 患者胰岛β细胞功能呈逐步恶化趋势。根据我们的结果,并结合 SEARCH 研究结果,建议在中国高风险或肥胖的儿科人群中,从 7 岁开始,对 T2D 进行早期筛查和干预。